Figure 2From: Parotid gland shrinkage during IMRT predicts the time to Xerostomia resolution Actuarial rate of physician-reported GR2+ xerostomia by both mid-treatment combined parotid gland shrinkage and mean weighted average parotid dose at planning. Low/high represent values below/above median values of 19.6% and 35.7Gy for mid-treatment shrinkage and mean combo parotid dose, respectively.Back to article page